Skip to main navigation
Solid Biosciences

IR Navigation

  • Overview
  • News & Events
    • Press Releases
    • Presentations
    • Events
  • Governance
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Report & Proxy Materials
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Contact Solid Biosciences
    • Email Alerts
« Solidbio.com

Solid Biosciences First Quarter 2022 Financial Results Call

Apr 27 8:00 AM EDT

Listen to Webcast

Supporting Materials

Q1 2022 Business Update and Financial Results Presentation 1.9 MB

Footer Links

  • Contact Us
  • Privacy
  • Terms and Conditions

© 2023 Solid Biosciences Inc. All rights reserved.

Solid Biosciences Inc., is a Charlestown, MA-based life science company committed to solving Duchenne muscular dystrophy and improving the lives of patients. Solid is currently developing gene therapies, disease modifying therapies and assistive devices, all targeting the many facets of the disease.

The characterization of the discovery and development efforts on this website, as well as the expectations associated with them, are reflective of the current state of development and may change as the Company progresses.